XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2020 7,814,572        
Balance at Dec. 31, 2020 $ 782 $ 119,844,026   $ (99,509,689) $ 20,335,119
Issuance of common stock for directors’ fees (in shares) 2,091        
Issuance of common stock for directors’ fees $ 0 7,510   0 7,510
Issuance of restricted common stock to employees and directors (in shares) 1,250        
Issuance of restricted common stock to employees and directors $ 0 0   0 0
Share-based compensation 0 133,638   0 133,638
Net loss 0 0   (851,431) (851,431)
Net loss 0 0   (851,431) (851,431)
Legal and commitment fees $ 0 (2,709)   0 (2,709)
Balance (in shares) at Mar. 31, 2021 7,817,913        
Balance at Mar. 31, 2021 $ 782 119,982,465   (100,361,120) 19,622,127
Balance (in shares) at Dec. 31, 2020 7,814,572        
Balance at Dec. 31, 2020 $ 782 119,844,026   (99,509,689) 20,335,119
Other comprehensive loss – Foreign currency translation adjustment         0
Net loss         (3,036,761)
Net loss         (3,036,761)
Balance (in shares) at Sep. 30, 2021 7,825,299        
Balance at Sep. 30, 2021 $ 783 120,079,118   (102,546,450) 17,533,451
Balance (in shares) at Mar. 31, 2021 7,817,913        
Balance at Mar. 31, 2021 $ 782 119,982,465   (100,361,120) 19,622,127
Issuance of common stock for directors’ fees (in shares) 1,748        
Issuance of common stock for directors’ fees $ 0 5,505   0 5,505
Issuance of restricted common stock to employees and directors (in shares) 1,250        
Share-based compensation $ 0 35,618   0 35,618
Net loss $ 0 0   (1,161,683) (1,161,683)
Restricted stock forfeited (in shares) (1,250)        
Net loss $ 0 0   (1,161,683) (1,161,683)
Legal and commitment fees $ 0 (2,519)   0 (2,519)
Balance (in shares) at Jun. 30, 2021 7,819,661        
Balance at Jun. 30, 2021 $ 782 120,021,069   (101,522,803) 18,499,048
Issuance of common stock for directors’ fees (in shares) 1,888        
Issuance of common stock for directors’ fees $ 0 6,008   0 6,008
Issuance of restricted common stock to employees and directors (in shares) 3,750        
Issuance of restricted common stock to employees and directors $ 1 0   0 1
Other comprehensive loss – Foreign currency translation adjustment         0
Share-based compensation 0 52,041   0 52,041
Net loss 0 0   (1,023,647) (1,023,647)
Net loss $ 0 0   (1,023,647) (1,023,647)
Balance (in shares) at Sep. 30, 2021 7,825,299        
Balance at Sep. 30, 2021 $ 783 120,079,118   (102,546,450) 17,533,451
Balance (in shares) at Dec. 31, 2021 7,853,759        
Balance at Dec. 31, 2021 $ 786 120,190,139 $ 0 (104,575,470) 15,615,455
Issuance of common stock for directors’ fees (in shares) 9,382        
Issuance of common stock for directors’ fees $ 1 22,019 0 0 22,020
Issuance of common stock pursuant to Swivel purchase agreement (in shares) 269,060        
Issuance of common stock pursuant to Swivel purchase agreement $ 27 599,977 0 0 600,004
Issuance of restricted common stock to employees and directors (in shares) 274,250        
Issuance of restricted common stock to employees and directors $ 27 (27) 0 0 0
Other comprehensive loss – Foreign currency translation adjustment 0 0 55,802 0 55,802
Share-based compensation 0 87,677 0 0 87,677
Net loss 0 0 0 (999,403) (999,403)
Net loss $ 0 0 0 (999,403) (999,403)
Balance (in shares) at Mar. 31, 2022 8,406,451        
Balance at Mar. 31, 2022 $ 841 120,899,785 55,802 (105,574,873) 15,381,555
Balance (in shares) at Dec. 31, 2021 7,853,759        
Balance at Dec. 31, 2021 $ 786 120,190,139 0 (104,575,470) 15,615,455
Other comprehensive loss – Foreign currency translation adjustment         (229,350)
Net loss         (5,120,869)
Net loss         (5,120,869)
Balance (in shares) at Sep. 30, 2022 8,452,621        
Balance at Sep. 30, 2022 $ 845 121,123,352 (229,350) (109,696,339) 11,198,508
Balance (in shares) at Mar. 31, 2022 8,406,451        
Balance at Mar. 31, 2022 $ 841 120,899,785 55,802 (105,574,873) 15,381,555
Issuance of common stock for directors’ fees (in shares) 9,117        
Issuance of common stock for directors’ fees $ 1 18,005 0 0 18,006
Issuance of restricted common stock to employees and directors (in shares) 1,250        
Other comprehensive loss – Foreign currency translation adjustment $ 0 0 (165,883) 0 (165,883)
Share-based compensation 0 57,379 0 0 57,379
Net loss $ 0 0 0 (1,718,957) (1,718,957)
Restricted stock forfeited (in shares) (1,250)        
Issuance of common stock for Employee stock purchase plan (in shares) 26,006        
Issuance of common stock for Employee stock purchase plan $ 2 39,123 0 0 39,125
Share based compensation for employee stock plan 0 8,314 0 0 8,314
Net loss $ 0 0 0 (1,718,957) (1,718,957)
Balance (in shares) at Jun. 30, 2022 8,441,574        
Balance at Jun. 30, 2022 $ 844 121,022,606 (110,081) (107,293,830) 13,619,539
Issuance of common stock for directors’ fees (in shares) 8,547        
Issuance of common stock for directors’ fees $ 1 18,008 0 0 18,009
Issuance of restricted common stock to employees and directors (in shares) 2,500        
Other comprehensive loss – Foreign currency translation adjustment $ 0 0 (119,269) 0 (119,269)
Share-based compensation 0 82,738 0 0 82,738
Net loss 0 0 0 (2,402,509) (2,402,509)
Net loss $ 0 0 0 (2,402,509) (2,402,509)
Balance (in shares) at Sep. 30, 2022 8,452,621        
Balance at Sep. 30, 2022 $ 845 $ 121,123,352 $ (229,350) $ (109,696,339) $ 11,198,508